ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

IQV IQVIA Holdings Inc

212.83
-0.49 (-0.23%)
2024年6月19日 - 終了
15分遅延
名称 銘柄コード 市場 種別
IQVIA Holdings Inc IQV NYSE 普通株式
  前日比 前日比 % 現在値 時刻
-0.49 -0.23% 212.83 09:00:00
始値 安値 高値 終値 前日終値
214.04 212.15 216.25 212.83 213.32
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/6/1221:00BWIQVIA Launches “One Home” Clinical Trial Technology Platform..
2024/6/1021:00BWIQVIA Institute: Innovative Therapies and Strong Pipeline to..
2024/5/1806:18EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/5/1421:00BWU.S. Medicines Spending Grew in 2023 as Greater Access..
2024/5/1105:35EDGAR2Form 8-K - Current report
2024/5/1006:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/1006:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/1006:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/1006:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/1006:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/1005:15BWIQVIA CFO Ron Bruehlman to Speak at the Bank of America..
2024/5/0220:00BWIQVIA Reports First-Quarter 2024 Results
2024/4/1605:15BWIQVIA to Announce First-Quarter 2024 Results on May 2, 2024
2024/4/0905:01BWIQVIA and Salesforce Expand Global Partnership to Accelerate..
2024/3/0706:15BWIQVIA CFO Ron Bruehlman to Speak at Barclays Annual Global..
2024/3/0209:49EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2622:00BWIQVIA Publishes its 2023 Environmental, Social and..
2024/2/2406:17EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
2024/2/2323:00BWGlobal Biopharma R&D Boasts Increased Funding, Productivity..
2024/2/2207:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2206:15BWIQVIA CFO Ron Bruehlman to Speak at Citi’s Unplugged Medtech..
2024/2/1707:20EDGAR2Form 144 - Report of proposed sale of securities
2024/2/1421:05EDGAR2Form 8-K - Current report
2024/2/1421:00BWIQVIA Reports Fourth-Quarter and Full-Year 2023 Results;..
2024/2/1407:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1407:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0907:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0907:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0907:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/0907:15EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
2024/2/0623:00BWIQVIA Named to Fortune® World's Most Admired Companies™..
2024/1/2506:15BWIQVIA to Announce Fourth-Quarter and Full-Year 2023 Results..
2024/1/1720:00BWGlobal Medicine Spending to Reach $2.3 Trillion by 2028 as..
2024/1/0319:41IHMARKETNEWSWall Street Highlights: Tesla’s Competition with BYD,..
2023/11/2922:30BWIQVIA Digital Enablement Named PM360 Trailblazer 2023..
2023/11/2906:19EDGAR2Form 8-K - Current report
2023/11/2206:15BWIQVIA CFO Ron Bruehlman to Speak at Evercore HealthCONx..
2023/11/1723:23BWIQVIA Announces Upsizing of its Allocation of New Term B..
2023/11/1523:28EDGAR2Form 8-K - Current report
2023/11/1523:11BWIQVIA Announces Pricing of Upsized Offering of Senior..
2023/11/1423:07BWIQVIA Announces Offering of Senior Secured Notes
2023/11/0622:00BWIQVIA’s Christina Mack Named 2023 PharmaVoice 100 Honoree
2023/11/0205:29EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0120:05EDGAR2Form 8-K - Current report
2023/11/0120:00BWIQVIA Reports Third-Quarter 2023 Results
2023/10/2321:00BWIQVIA to Provide Sanofi Its Orchestrated Customer Engagement..
2023/10/1120:30BWIQVIA and CEPI Collaborate to Strengthen Global Research..
2023/10/1020:02IHMARKETNEWSKeep An Eye Out: Pre-Market Movers And Recommendations
2023/10/1005:15BWIQVIA to Announce Third-Quarter 2023 Results on November 1,..
2023/10/0521:00BWPatient Organizations Gave $22 Billion in Grants for..

最近閲覧した銘柄

Delayed Upgrade Clock